Amylyx Pharmaceuticals said it would voluntarily remove its FDA-approved drug for amyotrophic lateral sclerosis from the market after a trial showed it doesn’t work.
Source link : https://www.washingtonpost.com/business/2024/04/04/amylyx-als-drug/
Author : Daniel Gilbert
Publish date : 2024-04-04 15:43:28
Copyright for syndicated content belongs to the linked Source.
In a rare move, maker of failed ALS drug removes it from the market
